Jason Raleigh Nunn
Director, Paratek Pharmaceuticals, Inc.
Companies
- Addex Therapeutics Ltd.Board member Mar 18, 2026 to now1
- Zenas BioPharma, Inc.Board member Sep 12, 2024 to now2
- Regulus Therapeutics Inc.Board member Jun 11, 2019 to now3
- Trevena IncBoard member Jan 30, 2014 to Jun 14, 20244
- Dermira (United States)Board member Oct 2, 2014 to Feb 24, 20205
- Paratek Pharmaceuticals, Inc.Board member Feb 2, 2009 to Oct 30, 20146
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Zenas BioPharma, Inc. ZBIO1,946,564 shares7$52.0M at $26.72Oct 14, 2025
- Addex Therapeutics Ltd. ADXN219,561 shares8$641.1K at $2.92Sep 2, 2026
- Regulus Therapeutics Inc.0 shares9Jun 25, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 2, 2026Granted 219,561 shares of Addex Therapeutics Ltd.8
- Sep 2, 2026Returned to company 219,561 shares of Addex Therapeutics Ltd.8
- Oct 9, 2025Bought 63,158 shares at $19.00 of Zenas BioPharma, Inc.7
- Jun 25, 2025Returned to company 62,500 shares of Regulus Therapeutics Inc.9
- Apr 30, 2025Granted 62,500 shares of Regulus Therapeutics Inc.10
- Sep 16, 2024Bought 441,176 shares at $17.00 of Zenas BioPharma, Inc.11
- Sep 16, 2024Converted 669,061 shares of Zenas BioPharma, Inc.11
- Sep 16, 2024Bought 441,176 shares at $17.00 of Zenas BioPharma, Inc.11
- Sep 16, 2024Converted 1,505,388 shares of Zenas BioPharma, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARZenas BioPharma, Inc., Board member
- 3
- 4SEC EDGARTrevena Inc, Board member
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Apr 30, 2025
- 11SEC EDGARForm 4 filed Sep 16, 2024